Inactive Instrument

Other languages Suda Ltd Australian S.E.

Equities

EMS

AU000000EMS2

End-of-day quote Australian S.E. Other stock markets
- ^AUD	-

Mar. 26	Arovella Therapeutics Receives Firm Commitments for About AU$12.5 Million Raise	MT
Mar. 20	Arovella Therapeutics' ALA-101-onCARlytics Collaboration with Imugene Ends; Shares Down 12%	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Arovella Therapeutics Receives Firm Commitments for About AU$12.5 Million Raise	Mar. 25
Arovella Therapeutics' ALA-101-onCARlytics Collaboration with Imugene Ends; Shares Down 12%	Mar. 19
Arovella Therapeutics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 27
Arovella Boosts Solid Tumor Pipeline with Novel CAR-iNKT Cell Armouring Tech License	Jan. 30
Arovella Therapeutics Manufactures GMP-Grade Lentiviral Vector for Cancer Therapy Product; Shares Climb 4%	Jan. 01
Arovella Therapeutics Ltd. Announces Change of Company Address	Dec. 06
Arovella Therapeutics Appoints CFO	Dec. 01
Arovella Therapeutics Limited Announces Changes to its Board	Nov. 30
Arovella Therapeutics Limited Announces Executive Changes	Nov. 30
Arovella Therapeutics Secures AU$2 Million Tax Rebate for Fiscal Year 2023	Nov. 20
Australian Shares Flat With Positive Bias Amid Hopes of US Fed Keeping Rates Steady	23-10-12
Arovella Therapeutics Secures License for Tumor Targeting Antibody; Shares Fall 6%	23-10-11
Arovella Therapeutics Limited Announces Retirement of David Simmonds as Non-Executive Director	23-09-06
Arovella Therapeutics Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-30
Arovella Therapeutics Raises AU$2.2 Million From Oversubscribed Share Purchase Plan	23-07-11
Arovella Therapeutics Extends Closing Date of Share Purchase Plan	23-06-29
Arovella Therapeutics, UNC Further Discussions on Enhanced iNKT Cells Performance	23-06-26
Arovella Therapeutics focused on driving ALA-101 into the clinic	23-06-08
Arovella Therapeutics Ends AU$4.1 Million Placement; Launches AU$1 Million Purchase Plan	23-06-07
Arovella Therapeutics progresses patient-focused iNKT vision	23-05-08

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Suda Ltd Australian S.E.

Equities

EMS

AU000000EMS2

Other languages

Filters